ArticleJournal of cardiothoracic surgery2026
Minimally invasive esophagectomy and omental transposition for the treatment of refractory aortoesophageal fistula.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAortoesophageal fistula (AEF) is a rare but frequently fatal condition. Endovascular aortic repair provides rapid hemorrhage control but does not address esophageal pathology, predisposing patients to recurrence and infection. CASE PRESENTATION: A 48-year-old woman developed recurrent AEF twelve months after thoracic endovascular aortic repair (TEVAR) performed for tuberculosis-related AEF. After failure of conservative management, she underwent a staged procedure consisting of cervical esophageal diversion, substernal gastric conduit reconstruction, robot-assisted esophagectomy, and omental transposition to isolate the aortic stent. Postoperative mediastinal infection occurred and was successfully treated with thoracoscopic debridement.
resultsThe patient resumed oral intake one month postoperatively. At 12-month follow-up, she remained asymptomatic with no evidence of recurrent fistula, mediastinal infection, or aortic stent graft contamination.
conclusionIn selected patients with refractory AEF after TEVAR, minimally invasive esophagectomy combined with omental transposition may provide effective esophageal control and protection of the aortic stent. Larger studies are required to validate this strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.